Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Preqin: 88% of investors plan to maintain or increase hedge fund allocations in next 12 months

Tuesday, August 27, 2013

Benedicte Gravrand, Opalesque Geneva:

The overall outlook for investors in alternative assets is positive, says Preqin, as most investors wish to either maintain or increase their exposure to alternatives (private equity, hedge funds, real estate, infrastructure) in the next 12 months or in the longer term. This applies to hedge funds investors too.

Preqin, an intelligence provider for the alternative asset industry, has just issued its latest Investor Outlook report for alternative assets for the second half of 2013, after interviewing 450 investors based in Europe (42%), North America (40%), Asia (9%) and other locations. Those investors include pension funds, insurance companies, asset managers, foundations, banks, family offices, and more.

Even if 26% of investors in hedge funds were not happy with the returns in the past year, this is the lowest level of dissatisfaction since 2008. Still, 60% of the interviewed investors have redeemed in the past year due to performance concerns.

However, there are still many investors who have a significant allocation to hedge funds, which suggests that they "do not allocate solely to generate returns, but also because of the liquidity, diversification and volatility dampening that the asset class can provide," says the report.

......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its